chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a pharmacist referring to a 64 year old patient of unknown gender. Information concerning medical history and concurrent condition was not reported. The patient had taken Sulfa and had unspecified pain medication. On 03-AUG-2015 the patient was vaccinated with ZOSTAVAX (0.65 ml, once, lot # L011533, expiration date: 03-JUL-2016, subcutaneous). There was no concomitant therapy reported. On 04-AUG-2015 (also reported as "a day later"), the patient experienced injection site red and injection site swelling. There was no treatment given for the events. No lab diagnostics studies were performed. The patient had sought medical attention via calling the pharmacy. The reporter was requesting a lot check. This case is one of several cases received from the same source. Additional information has been requested.
Patient called pharmacy on Monday, June 24, 2019 and reported he had developed a headache yesterday and still has one today ( this being vaccine number 2 in the shingrix series).  He also reports that he had chills on Sunday and still has a red "golf ball" sized redness at the injection site.  His PCP, was called and RMA was informed of what was going on and stated she would give him a call.  Tried to call the Standing Order physician, but got a message that physician was unable to be reached ( then called the PCP).  This Vaers will be faxed to the Standing Order physician.
Peripheral neuropathy; This case was reported by a lawyer and described the occurrence of peripheral neuropathy in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular) .5 mg. On an unknown date, unknown after receiving Shingrix, the patient experienced peripheral neuropathy (serious criteria GSK medically significant). On an unknown date, the outcome of the peripheral neuropathy was unknown.   It was unknown if the reporter considered the peripheral neuropathy to be related to Shingrix.
Severe vertigo, flu like symptoms, off balance, headache, feeling faint, pain in arm, palpitations, unable to stand up at first ER visit. Off and on tremors amd seizure like activity for years after vaccine. Dizziness and vestibular dysfunction start at post-vaccination to present. Delayed diagnosis of ortho static intolerance lapsing into pots, but symptoms began after first vaccine. Years of headaches when I did not suffer from headaches or migraines previously. Joint pain and cognitive decline that started in 2010 after the first vaccine. Short term memory loss that began after the first vaccine. Dry eyes that began after vaccine requiring prescription eye drops, gastrointestinal problems, visual disturbances, and over stimulation that was not previously ever experienced.
This case was reported by a other health professional via call center representative and described the occurrence of fever in a 4-year-old male patient who received KINRIX (batch number GM7X3, expiry date 13th November 2017). Concomitant products included MMRV. On 11th August 2016, the patient received KINRIX .5 ml. On 12th August 2016, 1 days after receiving KINRIX, the patient experienced fever (serious criteria other: serious as per reporter), injection site rash and injection site soreness. On an unknown date, the outcome of the fever, injection site rash and injection site redness were unknown. The reporter considered the fever, injection site rash and injection site redness to be almost certainly related to KINRIX. Additional details were provided as follows: This case was previously reported to a doctor. This case was reported by an administrator. The patient received KINRIX vaccine in his left thigh. On the same day, the patient received MMRV vaccine concomitantly. The patient experienced fever (102 degrees) with rash and redness at the injection site after receiving KINRIX vaccination. This case has been linked to case US2016117314, reported by the same reporter.
14 days of body chills, migraine headache, extreme fatigue, and diarrhea sine vaccine. Severe body chills 13 days after vaccine followed by mild fever.
Arm was warm/hot; Had lots of discomfort; Pain in arm; Arm turned red; Hard lump in her arm; A spontaneous report  was received from a consumer concerning a 82-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm was hot and had some pain, lots of discomfort, arm was warm and turned red, hard lump in her arm.  The patient's medical history was lymphedema in her legs which swells everyday. Concomitant medications reported were unknown.  On an unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) unknown route for prophylaxis of COVID-19 infection.  On 20 Feb 2021, approximately 3 days prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: 006M20A) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) arm was hot, had some pain and lots of discomfort. On 22 Feb 2021, after 2 days the patient experienced the event(s) arm was warm, turned red and had a hard lump in her arm.  Treatment included Tylenol and ice.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s) arm was hot and had some pain, lots of discomfort, arm was warm and turned red, hard lump in her arm was unknown.
Patient fainted after vaccination and fell on floor.  Had right knee pain.  IV was started and patient was transported to ER via EMS.
Pt. received Tdap 2-22-12. States (R) axilla pain with arm "heaviness & numbness" since 2-24-12. Called & spoke with center coordinator, 2-25-12. Came in clinic 2-26-12 BP 180/110 sent to ER.
After the vaccine was given the pt cried for two hours non-stop. The pt didn't have a temperature and was better that evening.
1:35 pm. Client was seen 15min. past vaccine C/O R arm numbness "drunk" feeling and dizziness and feeling "throat closing". Pt. able to walk to room for exam unaided. 140 pm. Client unable to talk clearly, was flushed, and R arm grip 50% weak compared to L arm grip. EMS called. 200 pm. EMS examined pt. now talking clearly and grips equal R and L hands and arm. Per EMS BS 292 mg/DL and B/P 183/92. Client refused transport to ER. and will consider going (with husband) to ER. Left clinic at 3 pm.
Diffuse (R) arm cellulitis 24 hours after DTaP with improvement subsequently with BENADRYL.
I had an upper sinus post-nasal drip, sore tonsils, fatigue.  I was mostly varying degrees of those symptoms.
chills; stiffness of his wrist or hands to elbow were tight like arthritis and were locking up on him; feels like he has the flu; Low grade fever; light sore throat; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 62-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/ lot number was not reported), intramuscular, administered in left arm on 30Mar2021 at 11:00 (at the age of 62 years) as dose 2, single for COVID-19 immunization. Medical history included Diabetes (Pre-Diabetes diagnosed a year and a half to two years ago), High blood pressure and dissected carotid arteries. Family medical history reported as mother was diabetic and had two strokes. His mother and father both died of a heart attack. Concomitant medications included metformin (METFORMIN), heart pill and two blood pressure pills. The patient was put on a heart pill 15 years ago and then maybe a year and a half ago, they put him on another blood pressure pill. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/ lot number was not reported), administered in right arm (unable to confirm if given in the muscle) on 09Mar2021 at 11:00 (at the age of 62 years) as dose 1, single for COVID-19 immunization and experienced no adverse events. On 31Mar2021, after second vaccination the patient experienced Low grade fever, Sore throat, Chills, Joint stiffness and Flu like symptoms. It was reported that he took the second shot yesterday(30Mar2021) and just wanted to know if he could take a Tylenol to treat the symptoms. He was running a low-grade fever It was getting worse. It started around 10:00 - 11:00 am and feels like he has the flu at around 11:30-12:00 and Chills at 13:45. There was no prescriber. He and his wife just signed up for it. Last night his wrist or hands to elbow were tight like arthritis and was locking up on him at 02:00. It felt like maybe his hands were like half open. He was exercising his hands moving it around and it got much better.  It started at 02:00 last night. He talked to some one and they said to exercise, and he moved his hands and arms around. No emergency room or physician's office was required, and they just said to let his doctor's office now. The outcome of all the events were unknown.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a consumer refers to a 59 year old female patient. The patient's medical history included caesarean section and ruptured appendix. The patient had a drug allergy to Betadine, where she lost a layer of skin and her skin was peeling. On 06-NOV-2013 the patient was vaccinated with ZOSTAVAX 1 shot. No concomitant medications were taken. On 07-NOV-2013, 2 days after onset of therapy the patient experienced injection site reaction. The reaction was a rash, hot to touch, raised, painful, wit no blisters, swollen, bruised, itchy and was 3 inches in size. No laboratory tests were done. The patient sought medical attention by contacting the physician. The patient took one Benadryl tablet as treatment. Patient was not hospitalized for the event. No product quality complaint was involved. The outcome of injection site reaction was reported as not recovered/not resolved. Causality assessment was not provided. Additional information is not expected.
Pt developed pain and difficulty  with movement of left shoulder. Pain radiates down shoulder to lower arm. Had decreased range of motion with abduction and rotations.
13AUG91 fever day of inject LDM sore & fevered; 14AUG91 2AM rt shoulder felt dislocated-sore could not hardly move it; pain went to neck & back area; 16AUG91 went to MD-chiropractor stated muscle spasms cause shoulder out pulled out place;
1 hr after shot. Pt's blood pressure dropped. He vomited, got diarrhea. He was observed and given fluids overnight.
Patient had a syncopal episode approx. 10 minutes following immunizations. She was dizzy, attempted to walk to clinic room door, and pass out. She lost consciousness for 30-60 seconds.
Irregular period. Was having period when received the Covid vaccine. Period ended at normal time. Got period again 5 days later.
Tiredness; Migraine; Nausea; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 27Mar2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  Caller is calling to report some side effects after receiving the first dose of the Pfizer Covid-19 vaccine. These side effects are tiredness, migraine, and nausea. She also mentioned she got the first dose of the vaccine on 27Mar2021.  The outcome of events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Patient contacted Health Center 6/11/22 stating 1 hour after administration severe chest pain, sob, muscle weakness, severe headache. Reports going to Emergency Room.
Information has been received from two healthcare workers referring to a patient of unknown age and gender. The patient's medical history was not reported. On 09-FEB-2015 the patient was received improperly stored VARIVAX (Merck) lot # K007979, expiration date 03-JUN-2016, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to medication.
This spontaneous report as received from a registered nurse refer to multiple unspecified patients of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored VAQTA lot # L045713, expiry date 14-JAN-2017 (strength, dose, route and site of administration were not reported). No adverse effects were reported. This is one of several cases received from the same reporter. Additional information has been requested.
brief simple febrile seizure 1 hr p/vax given-t101.8 R @ MD office p/sz; No further szs;
Information has been received from a pharmacy student concerning a 48 year old female with drug reactions/allergies to NSAIDS, lidocaine, morphine, Vicodin, statins and tomatoes and a medical history of glaucoma, depression, insomnia, and breast mass, who in the summer of 2008, was vaccinated with MMR II. Concomitant therapy included MENACTRA. the patient had an increased sedimentation rate after vaccination with MMR II. The sed rate increased from the 60's to 188. It was reported that the patient has not yet recovered. No product quality complaint involved. Additional information has been requested.
Herpes zoster; Information was received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the zoster vaccine live (ZOSTAVAX) by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On an unknown date in 2009, at approximately 61 years of age, the patient was administered the zoster vaccine live (ZOSTAVAX) by a healthcare provider at a physician's office. On an unknown date, the patient was treated by a physician for the following injury resulting from his zoster vaccine live (ZOSTAVAX) use: Herpes zoster. The patient claimed damages as a result of: injury to himself, loss of consortium, loss of services, and economic losses. The outcome of the herpes zoster is unknown.  Additional information has been requested.
Fever 100.2  Chills, aches, headache.  Lasted 24 hours, then totally gone.
3-18-21 4:01PM 'RASH TO RT ARM'. SLIGHT REDNESS TO POSTERIOR ASPECT. A/O, PINK, W/D, RESP REG WITH EASE. NO ACUTE DISTRESS. NO MOTOR OR SENSORY DEFICIT. 4:15PM WIFE TO DRIVE PT HOME. STATES HE EILL TAKE BENADRYL IF NEEDED. 3-19-21 10:40AM TC: PT STATES 'ALL GONE NOW'.
pt recv vax 18JUN96 & test revealed pt pregnant  WAES96111089; @ 22wk ultrasound was nl;@ 32wk pt exp preterm labor & preterm rupture of membrane;8MAY97 @ 33wk pt delivered 4lb 8oz male w/some resp & feedings problems & tx for sepsis
AFLURIA GIVEN TO PATIENT UNDER THE AGE OF 3. MOTHER NOTIFIED. INSTRUCTED TO CALL IF ANY ADVERSE REACTION.
4 days p/vax pt had fever of 102.2 R and diarrhea; no vomiting or excessive crying; pt taken to ER MD dx as viral synd;
I've had the following symptoms from the time I received the vaccine to today's date.  I've had a fluttering heart palpitation left arm throbbing pain, electrical throbbing pain in my head, twitching left eye, left leg numbness, left foot numbness., weakness mostly on my left foot, slight weakness on my right foot.  It feels like I have water build up in my left foot.  My primary doctor has treated the symptom with medication to help with the pain.  It did not help.  I have been to the emergency room, urgent care, and have seen my primary care doctor several times complaining of these symptoms.  The symptoms continue to get worse.
I Woke up in the middle of the night to numbness in my right arm and right leg. I was unable to move my right  limbs (this happened 3 nights in a row). tripping, dizziness, trouble finding words, loss of bladder control, tinnitus,  weakness on right side of my face, migraines, constant menstrual bleeding, and trouble with thinking/difficulty with executive  planning followed over the next 6-8 weeks. I was unable to work for over a month due to cognitive difficulties. After several hospital visits, MRI and CT scans, my neurologist (who believed this was my immune systems reaction to the vaccine)  successfully treated me with high dose steroids (to which  I responded well) and referred me a Clinic. He told me that he has seen many unreported issues like this in his practice.  I was subsequently referred to The  Clinic due to these symptoms. The head of neuro-immunology and rheumatology independently concluded that this long episode was a reaction to the Covid Vaccine.
PATIENT IS COMPLAINING OF PAIN IN HIS RIGHT SHOULDER JOINT.  HE IS UNABLE TO RAISE HIS ARM ABOVE HIS SHOULDERS.  HE IS HAVING TROUBLE SLEEPING DUE TO THE PAIN IN HIS SHOULDER JOINT.  HE IS TAKING TYLENOL AND SOMETIMES ALEVE FOR THE DISCOMFORT.
On 1/26/21 second COVID vaccine given, however there was a needle malfunction halfway through and only received half of the vaccine, with the rest being sprayed on employee.
Miscarriage Heavy bleeding causing severe anemia during miscarriage Intermittent heavy bleeding 2 months after miscarriage
This spontaneous report was received from a pharmacist regarding an unspecified infant of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 11-JUN-2015, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (dose and route of administratiton were not reported, lot number K010535 with expiration date 27-AUG-2016 or lot number K020216 with expiration date 17-SEP-2016). There were no adverse effects reported. This is on of several reports received from the same reporter. Additional information has been requested.
developed a rash; This is a spontaneous report from a contactable pharmacist (patient). A 49-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration on 12Jan2021 (Batch/Lot Number: EJ1686) as 2ND DOSE, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 for covid-19 immunisation. The patient experienced rash after 6 days of vaccination on 18Jan2021 and kept coming back, even though it has responded to topical steroids, a few days later came back. The patient visited dermatologist and undergone biopsy of rash on an unknown date in 2021 and then consulted allergist who thought patient might be allergic to something because of the clinical symptom. The allergist highly suspected the rash to be caused by the vaccine, it should be out of patient system by now. The patient states that she has seen two dermatologist and an allergist, and they suspect her rash was from the Pfizer Covid Vaccine. The patient took topical steroids as a treatment for which the rash has responded but after a few days later came back. It was reported that the rash was for more than a few months. The outcome of the event rash was not resolved.  No follow-up attempts are needed. No further information expected.; Sender's Comments: Based on the information provided, A possible contributory role of the suspect product to the development of rash cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate
This spontaneous report was received from a physician and a practice manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-APR-2016, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 0.5 ml prefilled syringe (lot # L024132, expiration date: 21-JAN-2017; dose and route were not provided). The vaccine was exposed to following separate temperature excursions: first lasting for 712 hours, with the lowest recorded temperature of 34 degrees Fahrenheit and the second lasting for 168 hours, with the lowest recorded temperature of 32 degrees Fahrenheit. The vaccine was stored in a refrigerator. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous case, initially received from the other-health professional on 23-Oct-2018, concerns an 81-year-old, elderly male patient. The patient did not have any medical history. The patient did not administer any concomitant medications. On 23-Oct-2018, the patient was administered inadequate dose of FLUAD (TIV) [route of administration: intramuscular, anatomical location: deltoid, batch number: 250801 and expiry date: 30-Jun-2019] (explicitly coded as incomplete dose administered). On the same day of vaccination, the liquid came out of the syringe as the needle was not attached properly (explicitly coded as syringe leakage and wrong technique in product usage process). The reporter assessed this case as non-serious.
Day of I felt light headed about two hours later. The next day had mild flu symptoms and the dizziness (vertigo) started in the afternoon
At 2AM on Sunday, November 28th (Less than 24 hours after receiving the COVID 19 Booster shot), patient fell off the toilet and could not get up.  He kept trying and trying to get up put simply couldn't.  He did not break any bones or have any sprains that would have prevented him from getting up.   It is important to note that he lived by himself and prior to receiving the COVID 19 Booster shot, he could get up off the floor without any problems.    He was found at 1PM on Monday, November 29th and taken to Hospital where he eventually died on Sunday, December 12, 2021.
Shingles; Vision problems; Information has been received from a lawyer regarding a case in litigation concerning a female patient (pt) of unknown age. The pt's medical history, concurrent conditions and concomitant medications were not provided. On or about 13-MAY-2013, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot#, expiration date were unknown) in a pharmacy for the long-term prevention of shingles and zoster-related conditions. Subsequent to pt's zoster vaccine live (ZOSTAVAX) inoculation, pt was treated by providers for shingles and vision problems. Pt claimed damages as a result of injury to herself. The outcome of shingles and vision problems was unknown and the causal relationship between the events and zoster vaccine live (ZOSTAVAX) was considered related.
Patient is a89y.o. year old  female with a h/o anemia, ESRD on HD presented to facility on 1/1/2022 from HD secondary to shortness of breath halfway through her session with pulse ox of 74%. Patient confused and unable to provide further history. Reportedly tested positive for COVID recently, however there is no record of positive testing in our system or other system. Last negative test recorded 11/6/2021. Attempts to reach family to clarify unsuccessful .